Translating cell survival and cell longevity into treatment strategies with SIRT1
about
Erythropoietin and diabetes mellitusFoxO Transcription Factors and Regenerative Pathways in Diabetes MellitusErythropoietin: new directions for the nervous systemShedding new light on neurodegenerative diseases through the mammalian target of rapamycinErythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life ExpectancyNew Insights for Oxidative Stress and Diabetes MellitusNovel applications of trophic factors, Wnt and WISP for neuronal repair and regeneration in metabolic diseaseWISP1: Clinical insights for a proliferative and restorative member of the CCN familyPRAS40 is an integral regulatory component of erythropoietin mTOR signaling and cytoprotectionWnt1 inducible signaling pathway protein 1 (WISP1) blocks neurodegeneration through phosphoinositide 3 kinase/Akt1 and apoptotic mitochondrial signaling involving Bad, Bax, Bim, and Bcl-xLPrevention of β-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K/mTOR pathway, Bad, and Bcl-xL.WISP1 (CCN4) autoregulates its expression and nuclear trafficking of β-catenin during oxidant stress with limited effects upon neuronal autophagy.Mammalian target of rapamycin signaling in diabetic cardiovascular diseaseRegeneration in the nervous system with erythropoietinA Critical Kinase Cascade in Neurological Disorders: PI 3-K, Akt, and mTOR.Oxidant stress and signal transduction in the nervous system with the PI 3-K, Akt, and mTOR cascadeWnt1 inducible signaling pathway protein 1 (WISP1) targets PRAS40 to govern β-amyloid apoptotic injury of microglia.Forkhead Transcription Factor FOXO1 Inhibits Angiogenesis in Gastric Cancer in Relation to SIRT1.Novel directions for diabetes mellitus drug discoveryWISP1 neuroprotection requires FoxO3a post-translational modulation with autoregulatory control of SIRT1Forkhead transcription factors: new considerations for alzheimer's disease and dementia.Programming apoptosis and autophagy with novel approaches for diabetes mellitus.Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer.Harnessing the Power of SIRT1 and Non-coding RNAs in Vascular Disease.Insights for Oxidative Stress and mTOR Signaling in Myocardial Ischemia/Reperfusion Injury under Diabetes.mTOR: Driving apoptosis and autophagy for neurocardiac complications of diabetes mellitus.SIRT1 and stem cells: In the forefront with cardiovascular disease, neurodegeneration and cancer.Forkhead Transcription Factors: Formulating a FOXO Target for Cognitive Loss.Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors.The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders.FoxO proteins in the nervous system.
P2860
Q26777878-669C8680-EAC7-4810-923D-1E83AC4F1AE6Q26800615-F9A0AF9C-5B71-4E41-8192-103AFB4FF938Q26828425-E110A0B7-8B4F-4C87-BA2A-027002D73EA7Q27015640-3087559C-ADF9-4F53-8C0A-8AE17A3A39D0Q28066377-68DFA348-AC34-4161-AC76-3BFFFA520DC1Q28080679-C2EE5A98-0516-4831-81D4-62C780EAAC0AQ28085715-DB21E221-AE77-4B4A-B201-F51358F594D2Q34381111-1B9A26A2-D07B-4693-856A-D1D4CD96EF7DQ34429082-3ACCF61D-EA02-4953-8F08-C5C1707C7C6CQ35742785-6EBC8E66-9463-4373-AD1B-2120BDB66D23Q35947388-E6148D42-F5BB-45E9-9AFB-C0E95B8F0BA8Q35965763-81ED833C-815C-495E-811C-D663A2E347A4Q36100715-108E33F1-313D-4121-9B5C-9E5EF8DAF6F0Q36247651-674AFF73-F798-4621-B3FE-C4A37A0D4934Q36379761-81508346-3529-4806-8FAA-44F40184B2CFQ36432388-5D715D3A-D8A3-4515-A711-1C918615ED1AQ36465550-50C045EB-BB7F-4CBF-BE56-62D50DC208B4Q36482596-D10CF26D-05EA-4538-BFC0-B030A4B47604Q36487424-F15D62A1-ACF9-42B6-94C8-B6A19A22C29CQ36597808-967D2205-5789-45E8-9FE0-CBCD76913397Q37064987-F97FE9B0-3254-43D4-A4B6-BF261397F30CQ38367977-0DA19980-39E5-4D50-891D-01430B9B1706Q38607849-3A4E8531-3A18-4597-9667-011813A1A992Q38655453-0F0DCFC5-BE52-4D90-8E2F-4FD542AB36C0Q38789540-C865B68B-AFA6-4423-8A71-3EF961B2E2B2Q39180915-9BEF2DAD-3D8E-4998-9BB0-5810B7729915Q42031136-BD52473D-4771-418B-B4C9-78D80B10FB3FQ43197576-19474B52-CBEF-49B8-9CEE-A64817469BA3Q45305554-A2C85D56-FFC2-491F-A7B4-E46EE8D06473Q51761339-E39AC86D-8ED5-4E4C-A7E7-C15FD76314FFQ52361076-2D1D8915-48D4-4AC7-BC59-8155AB87604AQ53622309-C46CC919-FE50-464B-AC9C-01C91D5AD3C1
P2860
Translating cell survival and cell longevity into treatment strategies with SIRT1
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Translating cell survival and cell longevity into treatment strategies with SIRT1
@ast
Translating cell survival and cell longevity into treatment strategies with SIRT1
@en
type
label
Translating cell survival and cell longevity into treatment strategies with SIRT1
@ast
Translating cell survival and cell longevity into treatment strategies with SIRT1
@en
prefLabel
Translating cell survival and cell longevity into treatment strategies with SIRT1
@ast
Translating cell survival and cell longevity into treatment strategies with SIRT1
@en
P2093
P2860
P1476
Translating cell survival and cell longevity into treatment strategies with SIRT1
@en
P2093
P2860
P304
P577
2011-01-01T00:00:00Z